STOCKWATCH
·
Pharmaceuticals
Management Change17 Mar 2026, 04:58 pm

Senores Pharmaceuticals Announces Changes in Senior Management Personnel

AI Summary

Senores Pharmaceuticals Limited has announced changes in its senior management personnel. Mr. Jatin Gajjar has been appointed as the Chief Technology Officer and categorized as Senior Management Personnel (SMP) of the Company. Meanwhile, Mr. Manohar Lalge, President - Research and Development, has tendered his resignation, ceasing to be the SMP of the Company. The changes are effective from March 17, 2026.

Key Highlights

  • Mr. Jatin Gajjar appointed as Chief Technology Officer and SMP of Senores Pharmaceuticals Limited.
  • Mr. Manohar Lalge resigns from his position as President - Research and Development and SMP of the Company.
  • Changes are effective from March 17, 2026.
SENORES
Pharmaceuticals
Senores Pharmaceuticals Ltd

Price Impact